FDA: Patients Who Respond Well to CML Drug Don’t Have to Stay on It Forever

The FDA updated the label of a cancer drug to include that certain patients with early chronic myeloid leukemia (CML) may be able to stop taking the treatment after they’ve responded well to it over time. The new update indicates that patients with CML who have been taking Tasigna (nilotinib) for 3 years or more, and whose leukemia has responded to treatment based on FDA criteria, may be able to discontinue use of the cancer drug. In the past, patients with CML remained on the drug indefinitely. While musculoskeletal symptoms such as body aches, bone pain and pain in extremities are among the most common side effects, Tasigna’s labeling contains a black-box warning alerting doctors and patients about the risk of abnormal heart rhythm (QT prolongation) and sudden death. Posted December 22, 2017. Via FDA.


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement